Hi Antonmesc,
It is sometimes possible to take a compound which is similar to another and derive effect information from one and apply it to the other. But this is seldom the case.
For example, MDMA is chemically similar to meth (which was the rational used by the DEA to place it under emergency scheduling). But meth can be very dangerous, and was the compound that produced Parkinsons disease in Ricaurte's test monkeys (this was where he "thought" he was using MDMA in the test series).
I know very little about MDA. But given its effects it appears to take a different pathway to produce experiences than does Ecstasy. Just the fact that MDA lasts lasts 3 times as long as MDMA indicates that it is doing "something different" than MDMA neurologically.
Antonmesc said:
Are you a doctor or work in the medical community? because you mentioned "We" when you refered to the medical community,
I'm not a physician, but in the past I've worked in a number of antidepressant research projects (mostly developing computer models for neuro function simulation).
I currently work in medical research related to the public health sector. I work directly with medical doctors (mostly epidemiologists) and biomedical researchers, as a contractor for a government agency that still prides itself on supplying honest ("non-political") information and research to benefit the public ("we" also work closely with health ministries and organizations in other countries, and with institutions such as the World Health Organization).
That's why I'm always harping about public health models and how the NIDA sponsored MDMA research doesn't fit with what we are seeing occur in the population of users.
Anyway, this will be my last post for a while. I've got to get a on plane in a couple of hours as this is the last day of my vacation. It's been nice chatting.
